Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype

Autor: Panagopoulos, Ioannis, Brunetti, Marta, Stoltenberg, Margrethe, Strandabø, Rønnaug, Staurseth, Julie, Andersen, Kristin, Kostolomov, Ilya, Hveem, Tarjei Sveinsgjerd, Lorenz, Susanne, Nystad, Tove Anita, Flægstad, Trond, Micci, Francesca, Heim, Sverre

Publikováno v: Panagopoulos, I., Brunetti, M., Stoltenberg, M., Strandabø, R.A.U., Staurseth, J., Andersen, K. ... Heim, S. (2019). Novel GTF2I-PDGFRB and IKZF1-TYW1 fusions in pediatric leukemia with normal karyotype. Experimental hematology and oncology, 8:12.

Externí odkaz: https://hdl.handle.net/10037/16286

Novel GTF2I - PDGFRB and IKZF1 - TYW1 fusions in pediatric leukemia with normal karyotype.

Autor: Panagopoulos I; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Brunetti M; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Stoltenberg M; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Strandabø RAU; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Staurseth J; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Andersen K; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Kostolomov I; 2Section for Applied Informatics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Hveem TS; 2Section for Applied Informatics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Lorenz S; 3Genomics Core Facility, Department of Core Facilities, Oslo University Hospital, Oslo, Norway., Nystad TA; 4Department of Pediatrics, Division of Child and Adolescent Health, University Hospital of North-Norway, 9038 Tromsø, Norway., Flægstad T; 4Department of Pediatrics, Division of Child and Adolescent Health, University Hospital of North-Norway, 9038 Tromsø, Norway.; 5Pediatric Research Group, Department of Clinical Medicine, Faculty of Health Science, The Arctic University of Norway-UiT, 9037 Tromsø, Norway., Micci F; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway., Heim S; 1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Nydalen, PO Box 49534, 0424 Oslo, Norway.; 6Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2019 May 29; Vol. 8, pp. 12. Date of Electronic Publication: 2019 May 29 (Print Publication: 2019).